Forest Laboratories Inc

Most Recent

  • Financials

    Why Tudor sold its position in Forest Laboratories?

    Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]

    By Samantha Nielson
  • Financials

    Why did Tudor buy Intercontinental Exchange?

    Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]

    By Samantha Nielson
  • uploads///BEAM
    Financials

    In high spirits? Why did Tudor open position in Beam?

    Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]

    By Samantha Nielson
  • uploads///ST UDE
    Fund Managers

    Millennium Management adds new position in St. Jude Medical

    St. Jude Medical, Inc. is a global medical device company founded in 1976. It has more than 20 principal operations and manufacturing facilities worldwide.

    By Adam Rogers
  • uploads///Q FDML New
    Consumer

    Why Carl Icahn Wants a 100% Stake in Federal-Mogul Holdings

    Icahn Enterprises (IEP) has been invested in auto parts maker Federal-Mogul Holdings (FDML) for almost a decade. Carl Icahn currently owns 82% of the company.

    By Jessica Stephans
  • uploads///CBST
    Fund Managers

    Elliott Management starts new position in Cubist Pharmaceuticals

    Cubist Pharmaceuticals has grown its pipeline via acquisitions. In 2013, it acquired Trius Therapeutics, obtaining rights to tedizolid phosphate.

    By Adam Rogers
  • uploads///northeast
    Fund Managers

    Millennium Management decreases position in Northeast Utilities

    Northeast Utilities reported a 12% rise in profits on lower operating costs and increased investments in big power transmission projects around New England.

    By Adam Rogers
  • Consumer

    Blue Ridge Capital buys a new position in Actavis

    Blue Ridge opened a new position in specialty pharmaceutical company Actavis Plc (ACT) that accounts for 2.27% of the fund’s portfolio.

    By Samantha Nielson
  • uploads///ACT
    Consumer

    Thomas Steyer’s Farallon Capital buys a new position in Actavis

    Farallon Capital Management opened a new 2.29% stake in specialty pharmaceutical company Actavis PLC (ACT).

    By Samantha Nielson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.